These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30419238)

  • 21. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM; Zhou R; Zhang M; Tan HR; Yu JQ
    Molecules; 2018 May; 23(6):. PubMed ID: 29861433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of acidic oligosaccharides on P-selectin of pulmonary hypertensive rats induced by monocrotaline].
    Feng Z; Hu Y; An NN; Feng WJ; Hu T; Mao YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Feb; 41(2):90-94. PubMed ID: 29429213
    [No Abstract]   [Full Text] [Related]  

  • 24. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL; Guan RJ; Li JJ
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.
    Varshney R; Ali Q; Wu C; Sun Z
    Hypertension; 2016 Nov; 68(5):1255-1263. PubMed ID: 27672025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
    Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
    Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naringenin adds to the protective effect of L-arginine in monocrotaline-induced pulmonary hypertension in rats: favorable modulation of oxidative stress, inflammation and nitric oxide.
    Ahmed LA; Obaid AA; Zaki HF; Agha AM
    Eur J Pharm Sci; 2014 Oct; 62():161-70. PubMed ID: 24878387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
    Hill NS; Warburton RR; Pietras L; Klinger JR
    J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.
    Ou ZJ; Wei W; Huang DD; Luo W; Luo D; Wang ZP; Zhang X; Ou JS
    Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1131-9. PubMed ID: 20215577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipose-derived stem cells attenuate pulmonary arterial hypertension and ameliorate pulmonary arterial remodeling in monocrotaline-induced pulmonary hypertensive rats.
    Luo L; Lin T; Zheng S; Xie Z; Chen M; Lian G; Xu C; Wang H; Xie L
    Clin Exp Hypertens; 2015; 37(3):241-8. PubMed ID: 25271670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Zopf DA; das Neves LA; Nikula KJ; Huang J; Senese PB; Gralinski MR
    Eur J Pharmacol; 2011 Nov; 670(1):195-203. PubMed ID: 21914448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Notch3 prevents monocrotaline-induced pulmonary arterial hypertension.
    Zhang Y; Xie X; Zhu Y; Liu L; Feng W; Pan Y; Zhai C; Ke R; Li S; Song Y; Fan Y; Fan F; Wang X; Li F; Li M
    Exp Lung Res; 2015; 41(8):435-43. PubMed ID: 26317171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
    Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
    Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.
    Mitani Y; Maruyama K; Sakurai M
    Circulation; 1997 Jul; 96(2):689-97. PubMed ID: 9244244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of simvastatin on rat pulmonary hypertension induced by high pulmonary blood flow and injected monocrotaline].
    Zhao L; Zhou TF; Liu HM; Li M; Dou H; Tang ZH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):463-5, 479. PubMed ID: 17593832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of drag-reducing polymers in a rat model of monocrotaline-induced pulmonary hypertension.
    Wang Y; Hu F; Mu X; Wu F; Yang D; Zheng G; Sun X; Gong K; Zhang Z
    Biorheology; 2016 Jan; 53(1):13-22. PubMed ID: 26889655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
    Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
    Ding M; Lei J; Qu Y; Zhang H; Xin W; Ma F; Liu S; Li Z; Jin F; Fu E
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):562-70. PubMed ID: 25636073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.